Patents by Inventor Ravishankar K. Iyer

Ravishankar K. Iyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11922220
    Abstract: Embodiments of systems, apparatuses and methods provide enhanced function as a service (FaaS) to users, e.g., computer developers and cloud service providers (CSPs). A computing system configured to provide such enhanced FaaS service include one or more controls architectural subsystems, software and orchestration subsystems, network and storage subsystems, and security subsystems. The computing system executes functions in response to events triggered by the users in an execution environment provided by the architectural subsystems, which represent an abstraction of execution management and shield the users from the burden of managing the execution. The software and orchestration subsystems allocate computing resources for the function execution by intelligently spinning up and down containers for function code with decreased instantiation latency and increased execution scalability while maintaining secured execution.
    Type: Grant
    Filed: April 16, 2019
    Date of Patent: March 5, 2024
    Assignee: Intel Corporation
    Inventors: Mohammad R. Haghighat, Kshitij Doshi, Andrew J. Herdrich, Anup Mohan, Ravishankar R. Iyer, Mingqiu Sun, Krishna Bhuyan, Teck Joo Goh, Mohan J. Kumar, Michael Prinke, Michael Lemay, Leeor Peled, Jr-Shian Tsai, David M. Durham, Jeffrey D. Chamberlain, Vadim A. Sukhomlinov, Eric J. Dahlen, Sara Baghsorkhi, Harshad Sane, Areg Melik-Adamyan, Ravi Sahita, Dmitry Yurievich Babokin, Ian M. Steiner, Alexander Bachmutsky, Anil Rao, Mingwei Zhang, Nilesh K. Jain, Amin Firoozshahian, Baiju V. Patel, Wenyong Huang, Yeluri Raghuram
  • Publication number: 20190189247
    Abstract: The present disclosure provides methods for accurately predicting the dynamics of symptom response to drugs or other interventions for the treatment of major depressive disorder or other psychological conditions. These methods can allow for a shortening of the time period necessary for the evaluation of a drug or other therapeutic intervention. These predictive methods are based on measured and/or self-reported symptom severity measures at two or more points in time. These measures are then discretized into symptom classes (e.g., low, moderate, severe) and the symptom classes are then applied to the predictive model to predict the progression of symptoms and/or the effectiveness of a drug or other therapeutic intervention.
    Type: Application
    Filed: December 14, 2018
    Publication date: June 20, 2019
    Applicants: The Board of Trustees of the University of Illinois, Mayo Foundation for Medical Education and Research
    Inventors: Ravishankar K. Iyer, Arjun Prasanna Athreya, Richard Merle Weinshilboum, Liewei Wang, William Victor Bobo, Mark Andrew Frye